Catalyst Pharmaceuticals
CPRX
$14.89
Share price
1.43%
Change (1 day)
-7.05%
Change (1 year)
Categories
Catalyst Pharmaceuticals (CPRX) - P/B ratio
P/B ratio as of April 2024 : 4.53
According to Catalyst Pharmaceuticals's latest financial reports the company has a price-to-book ratio of 4.53.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Catalyst Pharmaceuticals - P/B ratio (from 2006 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 4.62 | -28.29% |
| 2022-12-31 | 6.44 | 91.13% |
| 2021-12-31 | 3.37 | 64.94% |
| 2020-12-31 | 2.04 | -53.81% |
| 2019-12-31 | 4.42 | 13.91% |
| 2018-12-31 | 3.88 | -21.51% |
| 2017-12-31 | 4.95 | 123.49% |
| 2016-12-31 | 2.21 | -39.48% |
| 2015-12-31 | 3.66 | -37.18% |
| 2014-12-31 | 5.82 | 18.04% |
| 2013-12-31 | 4.93 | 300.46% |
| 2012-12-31 | 1.23 | -85.46% |
| 2011-12-31 | 8.47 | 143.49% |
| 2010-12-31 | 3.48 | 133.26% |
| 2009-12-31 | 1.49 | -37.75% |
| 2008-12-31 | 2.40 | -9.49% |
| 2007-12-31 | 2.65 | -13.07% |
| 2006-12-31 | 3.05 | |
| 2005-12-31 | N/A | |
| 2004-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 5.12 | 13.03% | 🇺🇸 USA |
 Pfizer PFE | 1.61 | -64.46% | 🇺🇸 USA |
 Abbott Laboratories ABT | 4.80 | 6.06% | 🇺🇸 USA |
 Sarepta Therapeutics
SRPT | 14.2 | 213.16% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | 0.0139 | -99.69% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | 3.11 | -31.45% | 🇺🇸 USA |